However, 2 recent studies found that the CD133− subpopulation of metastatic colon cancer cells in liver and ovarian cancer also initiate tumor formation, and ultimately induce greater tumor growth than the CD133+ subpopulation [21], [23]. This evidence concerns the gene PROM1 and malignant colon neoplasm.